| Model Number |
EVOLUTFX-23 |
| Medical Device Problem Codes |
Perivalvular Leak (1457); Inadequacy of Device Shape and/or Size (1583)
|
| Health Effect - Clinical Code |
Valvular Insufficiency/ Regurgitation (4449)
|
| Date of Event |
03/02/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
This regulatory report is being submitted due to retrospective review through capa 624392.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that during implant of this transcatheter bioprosthetic valve, the patient was sized for a 26 millimeter (mm).However, due to low coronary arteries, a 23mm valve was attempted for the implant.During the attempted implant, the valve was deployed to 80%.Severe paravalvular leak (pvl) was observed, and the valve was recaptured and removed from the patient.A 26mm medtronic valve was implanted successfully.No additional adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|